Loss of this inhibitory effect of SIN1-PH on mTOR increases mTORC2 signaling and occurs in cancer patient-derived mutations of SIN1-PH (D412G and R81T), rendering this SIN1 mutant oncogenic [49,51]. This evidence concerns the gene MTOR and cancer.